These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 33846399)

  • 1. Prognostic value of intratumoral Fusobacterium nucleatum and association with immune-related gene expression in oral squamous cell carcinoma patients.
    Neuzillet C; Marchais M; Vacher S; Hilmi M; Schnitzler A; Meseure D; Leclere R; Lecerf C; Dubot C; Jeannot E; Klijanienko J; Mariani O; Calugaru V; Hoffmann C; Lesnik M; Badois N; Borcoman E; Piaggio E; Kamal M; Le Tourneau C; Bieche I
    Sci Rep; 2021 Apr; 11(1):7870. PubMed ID: 33846399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Value of
    Hilmi M; Neuzillet C; Lefèvre JH; Svrcek M; Vacher S; Benhaim L; Dartigues P; Samalin E; Lazartigues J; Emile JF; Rigault E; Rioux-Leclercq N; de La Fouchardière C; Tougeron D; Cacheux W; Mariani P; Courtois L; Delaye M; Dangles-Marie V; Lièvre A; Bieche I
    Cancers (Basel); 2022 Mar; 14(7):. PubMed ID: 35406380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fusobacterium nucleatum Promotes Cisplatin-Resistance and Migration of Oral Squamous Carcinoma Cells by Up-Regulating Wnt5a-Mediated NFATc3 Expression.
    Da J; Wang X; Li L; Xu Y
    Tohoku J Exp Med; 2021 Apr; 253(4):249-259. PubMed ID: 33840648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Significance of
    Zhang N; Liu Y; Yang H; Liang M; Wang X; Wang M; Kong J; Yuan X; Zhou F
    Pathol Oncol Res; 2021; 27():1609846. PubMed ID: 34305476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Localization of Fusobacterium nucleatum in oral squamous cell carcinoma and its possible directly interacting protein molecules: A case series.
    He X; Ma X; Meng Z; Han Z; Chen W
    Histol Histopathol; 2023 Aug; 38(8):929-939. PubMed ID: 36478348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fusobacterium nucleatum impairs DNA mismatch repair and stability in patients with squamous cell carcinoma of the head and neck.
    Hsueh CY; Lau HC; Huang Q; Gong H; Sun J; Cao P; Hu C; Zhang M; Tao L; Zhou L
    Cancer; 2022 Sep; 128(17):3170-3184. PubMed ID: 35789992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resveratrol is an inhibitory polyphenol of epithelial-mesenchymal transition induced by Fusobacterium nucleatum.
    Min J; Mashimo C; Nambu T; Maruyama H; Takigawa H; Okinaga T
    Arch Oral Biol; 2024 Apr; 160():105897. PubMed ID: 38290225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysbiosis of salivary microbiome and cytokines influence oral squamous cell carcinoma through inflammation.
    Rai AK; Panda M; Das AK; Rahman T; Das R; Das K; Sarma A; Kataki AC; Chattopadhyay I
    Arch Microbiol; 2021 Jan; 203(1):137-152. PubMed ID: 32783067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conversion from epithelial to partial-EMT phenotype by Fusobacterium nucleatum infection promotes invasion of oral cancer cells.
    Shao W; Fujiwara N; Mouri Y; Kisoda S; Yoshida K; Yoshida K; Yumoto H; Ozaki K; Ishimaru N; Kudo Y
    Sci Rep; 2021 Jul; 11(1):14943. PubMed ID: 34294795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral microbial dysbiosis and its performance in predicting oral cancer.
    Su SC; Chang LC; Huang HD; Peng CY; Chuang CY; Chen YT; Lu MY; Chiu YW; Chen PY; Yang SF
    Carcinogenesis; 2021 Feb; 42(1):127-135. PubMed ID: 32621740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fusobacterium nucleatum and T Cells in Colorectal Carcinoma.
    Mima K; Sukawa Y; Nishihara R; Qian ZR; Yamauchi M; Inamura K; Kim SA; Masuda A; Nowak JA; Nosho K; Kostic AD; Giannakis M; Watanabe H; Bullman S; Milner DA; Harris CC; Giovannucci E; Garraway LA; Freeman GJ; Dranoff G; Chan AT; Garrett WS; Huttenhower C; Fuchs CS; Ogino S
    JAMA Oncol; 2015 Aug; 1(5):653-61. PubMed ID: 26181352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of
    Borowsky J; Haruki K; Lau MC; Dias Costa A; Väyrynen JP; Ugai T; Arima K; da Silva A; Felt KD; Zhao M; Gurjao C; Twombly TS; Fujiyoshi K; Väyrynen SA; Hamada T; Mima K; Bullman S; Harrison TA; Phipps AI; Peters U; Ng K; Meyerhardt JA; Song M; Giovannucci EL; Wu K; Zhang X; Freeman GJ; Huttenhower C; Garrett WS; Chan AT; Leggett BA; Whitehall VLJ; Walker N; Brown I; Bettington M; Nishihara R; Fuchs CS; Lennerz JK; Giannakis M; Nowak JA; Ogino S
    Clin Cancer Res; 2021 May; 27(10):2816-2826. PubMed ID: 33632927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of CXCL2-mediated crosstalk between tumor cells and macrophages in Fusobacterium nucleatum-promoted oral squamous cell carcinoma progression.
    Nie F; Zhang J; Tian H; Zhao J; Gong P; Wang H; Wang S; Yang P; Yang C
    Cell Death Dis; 2024 Apr; 15(4):277. PubMed ID: 38637499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Fusobacterium nucleatum with immunity and molecular alterations in colorectal cancer.
    Nosho K; Sukawa Y; Adachi Y; Ito M; Mitsuhashi K; Kurihara H; Kanno S; Yamamoto I; Ishigami K; Igarashi H; Maruyama R; Imai K; Yamamoto H; Shinomura Y
    World J Gastroenterol; 2016 Jan; 22(2):557-66. PubMed ID: 26811607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fusobacterium nucleatum and oral cancer: a critical review.
    McIlvanna E; Linden GJ; Craig SG; Lundy FT; James JA
    BMC Cancer; 2021 Nov; 21(1):1212. PubMed ID: 34774023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigating the Association Between Fusobacterium nucleatum and Oral Squamous Cell Carcinoma: A Pilot Case-Control Study on Tissue Samples.
    Kaliamoorthy S; Priya Sayeeram S; SundarRaj S; Balakrishnan J; Nagarajan M; Samidorai A
    Cureus; 2023 Oct; 15(10):e47238. PubMed ID: 38022043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Periodontal pathogens Porphyromonas gingivalis and Fusobacterium nucleatum promote tumor progression in an oral-specific chemical carcinogenesis model.
    Binder Gallimidi A; Fischman S; Revach B; Bulvik R; Maliutina A; Rubinstein AM; Nussbaum G; Elkin M
    Oncotarget; 2015 Sep; 6(26):22613-23. PubMed ID: 26158901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fusobacterium nucleatum persistence and risk of recurrence after preoperative treatment in locally advanced rectal cancer.
    Serna G; Ruiz-Pace F; Hernando J; Alonso L; Fasani R; Landolfi S; Comas R; Jimenez J; Elez E; Bullman S; Tabernero J; Capdevila J; Dienstmann R; Nuciforo P
    Ann Oncol; 2020 Oct; 31(10):1366-1375. PubMed ID: 32569727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intratumoral Microbiota Changes with Tumor Stage and Influences the Immune Signature of Oral Squamous Cell Carcinoma.
    Pratap Singh R; Kumari N; Gupta S; Jaiswal R; Mehrotra D; Singh S; Mukherjee S; Kumar R
    Microbiol Spectr; 2023 Aug; 11(4):e0459622. PubMed ID: 37409975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Dietary Patterns With Risk of Colorectal Cancer Subtypes Classified by Fusobacterium nucleatum in Tumor Tissue.
    Mehta RS; Nishihara R; Cao Y; Song M; Mima K; Qian ZR; Nowak JA; Kosumi K; Hamada T; Masugi Y; Bullman S; Drew DA; Kostic AD; Fung TT; Garrett WS; Huttenhower C; Wu K; Meyerhardt JA; Zhang X; Willett WC; Giovannucci EL; Fuchs CS; Chan AT; Ogino S
    JAMA Oncol; 2017 Jul; 3(7):921-927. PubMed ID: 28125762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.